214 related articles for article (PubMed ID: 25256235)
1. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.
Reed GL; Houng AK; Wang D
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2586-93. PubMed ID: 25256235
[TBL] [Abstract][Full Text] [Related]
2. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
Houng AK; Wang D; Reed GL
Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
[TBL] [Abstract][Full Text] [Related]
3. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
4. α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.
Reed GL; Houng AK; Singh S; Wang D
Semin Thromb Hemost; 2017 Mar; 43(2):191-199. PubMed ID: 27472428
[TBL] [Abstract][Full Text] [Related]
5. Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Singh S; Houng AK; Wang D; Reed GL
J Thromb Haemost; 2016 Sep; 14(9):1822-32. PubMed ID: 27319402
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
7. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
[TBL] [Abstract][Full Text] [Related]
8. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
9. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
Simão F; Ustunkaya T; Clermont AC; Feener EP
Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Saleem S; Wang D; Zhao T; Sullivan RD; Reed GL
Neuroscience; 2021 Apr; 460():120-129. PubMed ID: 33465414
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.
Tabrizi P; Wang L; Seeds N; McComb JG; Yamada S; Griffin JH; Carmeliet P; Weiss MH; Zlokovic BV
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2801-6. PubMed ID: 10559029
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
Jin R; Xiao AY; Chen R; Granger DN; Li G
Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
[TBL] [Abstract][Full Text] [Related]
13. α2 Antiplasmin and microvascular thrombosis in ischemic stroke.
Su EJ; Lawrence DA
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2522-3. PubMed ID: 25411105
[No Abstract] [Full Text] [Related]
14. Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis).
Kager LM; Weehuizen TA; Wiersinga WJ; Roelofs JJ; Meijers JC; Dondorp AM; van 't Veer C; van der Poll T
Am J Respir Crit Care Med; 2013 Oct; 188(8):967-75. PubMed ID: 23992406
[TBL] [Abstract][Full Text] [Related]
15. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
Zhang ZG; Zhang L; Tsang W; Goussev A; Powers C; Ho KL; Morris D; Smyth SS; Coller BS; Chopp M
Brain Res; 2001 Sep; 912(2):181-94. PubMed ID: 11532435
[TBL] [Abstract][Full Text] [Related]
16. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Jin R; Xiao AY; Liu S; Wang M; Li G
Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice.
Suzuki Y; Nagai N; Collen D
J Thromb Haemost; 2004 Sep; 2(9):1617-21. PubMed ID: 15333039
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.
Eddy JL; Schroeder JA; Zimbler DL; Bellows LE; Lathem WW
Infect Immun; 2015 Dec; 83(12):4837-47. PubMed ID: 26438794
[TBL] [Abstract][Full Text] [Related]
20. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
García-Yébenes I; García-Culebras A; Peña-Martínez C; Fernández-López D; Díaz-Guzmán J; Negredo P; Avendaño C; Castellanos M; Gasull T; Dávalos A; Moro MA; Lizasoain I
Stroke; 2018 Sep; 49(9):2163-2172. PubMed ID: 30018160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
